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Summary
Targeted genome-editing technology using designed nucleases has been evolving rapidly, and its
applications are widely expanding in research, medicine and biotechnology. Using this genome-
modifying technology, researchers can precisely and efficiently insert, remove or change specific
sequences in various cultured cells, micro-organisms, animals and plants. This genome editing is
based on the generation of double-strand breaks (DSBs), repair of which modifies the genome
through nonhomologous end-joining (NHEJ) or homology-directed repair (HDR). In addition,
designed nickase-induced generation of single-strand breaks can also lead to precise genome
editing through HDR, albeit at relatively lower efficiencies than that induced by nucleases. Three
kinds of designed nucleases have been used for targeted DSB formation: zinc-finger nucleases,
transcription activator-like effector nucleases, and RNA-guided engineered nucleases derived
from the bacterial clustered regularly interspaced short palindromic repeat (CRISPR)–Cas
(CRISPR-associated) system. A growing number of researchers are using genome-editing
technologies, which have become more accessible and affordable since the discovery and
adaptation of CRISPR-Cas9. Here, the repair mechanism and outcomes of DSBs are reviewed and
the three types of designed nucleases are discussed with the hope that such understanding will
facilitate applications to genome editing.
Introduction
To understand how genotypes influence phenotypes, researchers
have traditionally used targeted gene inactivation via homologous
recombination (HR). However, this approach is time-consuming
and challenging in plant cells mainly because the efficiency of
such HR is extremely low (ranging from 1 in 104 to 105 of
transformed cells) (Offringa et al., 1990; Paszkowski et al., 1988).
Alternatively, targeted gene knockdown by RNA interference
(RNAi) has become popular as a method for targeted inhibition of
specific endogenous genes, because it is rapid, inexpensive and
suited for high-throughput applications. However, knockdown of
gene expression by RNAi is usually incomplete and only leads to
temporary inhibition (Krueger et al., 2007). Furthermore, RNAi-
based knockdown is often complicated with unpredictable
off-target effects (Jackson et al., 2003).
A new genome-editing technology, based on designed
nucleases that produce site-specific DNA double-strand breaks
(DSBs), has emerged that enables precise and efficient targeted
genetic modifications in various cells and organisms, including
plants. In the absence of homologous templates, DSBs trigger
error-prone nonhomologous end-joining (NHEJ), resulting in
targeted mutagenesis (Bibikova et al., 2002; Rouet et al., 1994;
Salomon and Puchta, 1998). In contrast, in the presence of an
appropriate homologous template, DSBs can lead to precise
homology-directed repair (HDR), which is at least two orders of
magnitude more efficient than the conventional donor DNA-
based gene inactivation method, which takes place in the
absence of an appropriate DSB (Puchta et al., 1993; Rouet
et al., 1994).
At the end of 2011, Nature Methods chose genome editing
with designed nucleases, including zinc-finger nucleases (ZFNs)
and transcription activator-like effector nucleases (TALENs), as
the ‘Method of the Year’. Soon after, in January 2013, several
groups independently reported the use of a novel class of
nucleases derived from the bacterial clustered regularly inter-
spaced short palindromic repeat (CRISPR)-Cas9 system as a
genome-editing tool (Cho et al., 2013; Cong et al., 2013;
Hwang et al., 2013; Jiang et al., 2013; Jinek et al., 2013; Mali
et al., 2013b). This latter class of nucleases, also referred to as
RNA-guided engineered nucleases (RGENs), has been rapidly
evolving since then.
Here, we review the three types of designed nucleases for
inducing targeted DSBs. First, we will discuss the generation,
repair and effects of DNA DSBs. Next, we will describe and
compare the general features of ZFNs, TALENs and RGENs.
Finally, we will speculate as to future directions and applications
of designed nucleases for genome editing.
Double-strand breaks
The generation of DSBs is a key process in targeted genome
editing. DSBs are a form of DNA damage that occurs when both
DNA strands are cleaved. Genetically, DSBs result in discontinu-
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ities of genetic information, leading to perturbation or inactiva-
tion of that information. Chemically, DSBs are discontinuities in
the covalently linked carbon-phosphate backbones of both
strands. Whereas some physiologic DSBs are generated in early-
stage lymphocytes of the vertebrate immune system to produce
antibody diversity, most DSBs are generated by pathologic causes
that include ionizing radiation and oxidative free radicals (Lieber
and Karanjawala, 2004; Lieber et al., 2003). DSBs in mammalian
cells can be repaired by homologous recombination (HR) and
NHEJ. Traditionally, one of the most popular methods for gene
modification was based on using HR, a technique that has been
widely employed in mouse embryonic stem cells to generate
germ-line knockout or knockin mice. However, the efficiency of
HR events is extremely low (ranging from 1 in 106 to 1 in 107) in
higher eukaryotes. In 1994, the discovery that the introduction of
a DSB increases the frequency of HR by at least 2–3 orders of
magnitude (Puchta et al., 1993; Rouet et al., 1994) led to
efficient HR-based genome editing using programmable
nucleases that generate DSBs at specific loci. Furthermore, in
the absence of a homologous template, NHEJ repair of DSBs can
lead to targeted gene disruption due to the error-prone nature of
this process (Bibikova et al., 2002; Rouet et al., 1994). Such
HR- or NHEJ-mediated repair of DSBs generated with pro-
grammable nucleases allows exquisitely precise genome modifi-
cations, such as gene disruptions (knockouts), insertions
(knockins) and corrections (substitutions), as well as chromosomal
rearrangements (Figure 1).
Repair of DNA double-strand breaks
Nonhomologous end-joining
Nonhomologous end-joining is a natural pathway for repairing
DSBs through the ligation of two broken DNA ends. NHEJ
often terminates the repair with errors and can lead to the
introduction of small insertions and deletions (collectively called
indels) at the site of the DSB (Figure 1a). Small indels often
induce frameshifts, causing gene knockout by a combination of
two mechanisms: premature truncation of the encoded protein
and non-sense-mediated decay of the mRNA transcript (the
latter is not always particularly efficient). NHEJ can occur during
any phase of the cell cycle. In higher eukaryotes, NHEJ, rather
than HDR, is the dominant DSB repair system (Lieber, 2010;
Puchta, 2005).
(a)
(c)(b)
Homology-directed repairNon-homologous end-joining
Double strand break
Cleavage by designed nuclease
Donor DNADonor DNA
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ssODN
Cleavage by two nucleases
on a single chromosome
Two DSBs
DNA repair by non-homologous end joining
Large deletion
Or
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Cleavage by two nucleases
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DNA repair by non-homologous end joining
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Gene correction or point mutagenesisGene insertionSmall INDELs (insertion and deletion)
Figure 1 Outcome of genome editing through designed nuclease-based generation of double-strand breaks (DSBs). (a) In the absence of donor
templates, nuclease-induced DSBs can be repaired by error-prone nonhomologous end-joining, which consequently often results in small insertions or
deletions (indels). With appropriate donor DNA or single-strand oligodeoxynucleotide (ssODN), DSBs can be repaired by homology-directed repair, which
can lead to sequence insertion and nucleotide substitution. (b) When designed nucleases generate two different DSBs on a single chromosome, the
flanking region can be deleted or inverted. (c) When designed nucleases generate DSBs on two different chromosomes, interchromosomal translocations
can be induced.
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Ligation of two DNA ends through NHEJ requires various repair
enzymes. Both Ku-dependent and Ku-independent NHEJ sub-
pathways exist. In classical, Ku-dependent NHEJ, the DNA end
protection factors (which form the Ku70/80 heterodimer) bind to
the ends of the DNA strand at the break site and recruit the repair
enzyme ligase IV and its cofactor. During NHEJ, annealing of
exact complementary single-stranded ends can result in accurate
repair. However, most breaks occurring in the cell do not have
complementary ends, and NHEJ frequently proceeds through the
annealing of short (1–4 bp) microhomologous sequences. Often,
DNA end processing leads to the formation of small (1–4 bp)
insertions and/or deletions (indels) at the DSB site (Lieber, 2010).
The alternative end-joining (Ku-independent) pathway can repair
DSBs without Ku-dependent pathway factors. Microhomology-
mediated end-joining (MMEJ) is a major Ku-independent NHEJ
pathway. MMEJ uses 5- to 25-bp microhomology sequences
during the alignment of broken ends before joining. MMEJ
proceeds by annealing the microhomology regions, removing
overhanging nucleotides and filling in the missing base pairs.
Thus, MMEJ frequently produces a longer deletion at the DSB site
than does Ku-dependent NHEJ (McVey and Lee, 2008).
Homology-directed repair
Homology-directed repair is a template-dependent pathway for
DSB repair (Figure 1a). In contrast to error-prone NHEJ pathways,
HDR is precise. The defining step of HDR is the paring of a single-
stranded DNA that is processed from a broken or damaged DNA
site with its complement in a homologous region of undamaged
double-stranded DNA (for example, the sister chromatid). This
pairing is catalysed by the interaction of DNA strand exchange
proteins such as RecA and Rad51 with a series of DNA substrates
(Sarbajna and West, 2014). Unlike NHEJ, HDR is restricted to late
S/G2 phases of the cell cycle.
Outcomes of DSB repair
Through the NHEJ mechanism
Small indels that are created at the target site through error-
prone NHEJ can result in target gene knockout through the
mechanisms discussed above. This process simply requires an
appropriate designed nuclease; a homologous template is not
needed. One of the standard methods for determining gene
function is to observe the phenotype of knockout cells and
organisms that lack functional copies of the gene of interest.
NHEJ-mediated repair of DSBs that are generated by engineered
nucleases has been widely used to produce various knockout cell
and organism models (Kim and Kim, 2014; Segal and Meckler,
2013).
Two concurrent DSBs induced by two different designed
nucleases, targeting regions far away from one another on a
single chromosome, can give rise to chromosomal rearrange-
ments or structural variations (Figure 1b,c). Deletions, inversions
and translocations of large chromosomal segments (up to a few
megabase pairs in length) have been achieved using three
different types of designed nucleases (Carlson et al., 2012; Cong
et al., 2013; Gupta et al., 2013; Kim et al., 2013a; Lee et al.,
2010, 2012; Petolino et al., 2010; Qi et al., 2013b; Xiao et al.,
2013). By inducing DSBs on two different chromosomes, inter-
chromosomal translocations have also been made (Brunet et al.,
2009; Cho et al., 2014) (Figure 1c). Recently, various cancer
models containing chromosomal rearrangements have been
generated using designed nucleases (Lagutina et al., 2015;
Maddalo et al., 2014). This method has also been used to rescue
a disease genotype caused by a chromosomal inversion (Lee
et al., 2012; Park et al., 2014).
Through the HDR mechanism
In the vast majority of cases in plant and animal cells, transgene
DNA integrates into nontargeted, random genomic locations. If
the transgene integrates into undesired sites, it may inactivate
essential genes or, in the case of mammalian cells, activate proto-
oncogenes (Hacein-Bey-Abina et al., 2003). Also, randomly
integrated transgenes can be epigenetically silenced depending
on the site of integration. In contrast, targeted gene knockin
using designed nucleases has several advantages. Targeted DSB
generation with programmable nucleases allows the insertion of
desired genes into predetermined locations such as ‘safe harbour’
sites with enhanced efficiency (Doyon et al., 2011; Hockemeyer
et al., 2011; Li et al., 2011). ‘Safe harbour’ sites are locations in
the genome where therapeutic transgenes can be integrated and
expressed in a predictable manner without perturbing endoge-
nous gene expression (Sadelain et al., 2012). To insert genes of
interest into specific loci including genomic safe harbours, the
nuclease is delivered into cells together with a targeting vector
(donor DNA) that comprises the transgene and flanking arms that
are homologous to the sequences near the target region
(Figure 1a).
Point mutations can be corrected or single-nucleotide varia-
tions can be introduced in the target site of the genome through
codelivery of designed nucleases and targeting vectors (Bibikova
et al., 2001, 2003; Porteus and Baltimore, 2003) or single-
stranded oligodeoxynucleotides (ssODNs) (Chen et al., 2011)
(Figure 1a). In the case of donor DNA, the preparation is often
cumbersome and time-consuming. However, ssODNs can be
easily designed and synthesized (Chen et al., 2011). This ssODN-
coupled point mutagenesis has been used in an easy, precise and
efficient manner for the generation of disease models in animals
(Cui et al., 2011; Wang et al., 2013; Wefers et al., 2013) and
human cells (Soldner et al., 2011), for therapeutic purposes in an
animal model of disease (Yin et al., 2014) and for introducing
point mutations in the plant genome (Shan et al., 2013).
Three types of designed nucleases
Zinc-finger nucleases
Zinc-finger nucleases are composed of a zinc-finger protein (ZFP)
domain, which is a designable, sequence-specific DNA-binding
domain, and a nonspecific DNA cleavage domain derived from
the type II restriction enzyme FokI (Kim et al., 1996) (Figure 2).
The FokI nuclease domain must be dimerized to cleave DNA
(Bitinaite et al., 1998); thus, two different ZFN monomers, each
binding to a different strand, are required for an active nuclease.
A ZFN is designed as a pair of monomers that recognizes two
sequences, which flank the target site and are separated by a
5- to 7-bp spacer sequence (Figure 2a). One monomer binds to
the forward strand and the other to the reverse strand.
The required dimerization of ZFN monomers expands the
length of recognition sites, which substantially increases ZFN
specificity. Each zinc-finger domain usually recognizes a 3-bp
DNA sequence (Wolfe et al., 2000), and several domains arrayed
in tandem can bind to proportionately longer nucleotide
sequences (3–6 zinc-finger domains are used to generate a single
ZFN subunit that binds to DNA sequences of 9–18 bp)
(Figure 2a). Importantly, the specificity of a zinc-finger DNA-
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binding domain can be altered by mutagenesis (Desjarlais and
Berg, 1992; Rebar and Pabo, 1994). Such manipulation of ZFPs to
alter their binding specificity is a key feature of constructing a
designed nuclease. New ZFPs with desired specificities can be
constructed by modularly assembling precharacterized zinc fingers
(Bae et al., 2003; Bibikova et al., 2002, 2003; Kim et al., 2010;
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Figure 2 Structure of zinc-finger nucleases (ZFNs). Each ZFN domain is shown in the same colour in both (a) and (b). (a) A schematic representation of a
ZFN dimer bound to DNA. Each ZFN is composed of a zinc-finger protein at the amino terminus and the FokI nuclease domain at the carboxyl terminus.
The target sequence of a ZFN pair is typically 18–36 bp in length, excluding a 5- to 7-bp spacer. (b) A computer-generated model structure of a ZFN pair
bound to DNA. Each zinc finger consists of approximately 30 amino acids in a bba arrangement. The catalytic residues for FokI nuclease activity are
presented as purple sticks. Residues in a-helix of zinc finger that contact 3 bp in the major groove of target DNA are shown as sticks (close-up view of inset).
The side chains of the conserved two Cys and two His residues coordinating a Zn2+ ion (depicted as a purple ball) are shown from a different
direction (close-up view of inset). This model was compiled from crystal structures of zinc fingers bound to DNA (Protein Database 1AAY) (Elrod Erickson
et al., 1996) and the FokI restriction endonuclease in the absence of DNA (2FOK) (Wah et al., 1998).
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Segal et al., 2003). Cell-based selection methods and modular
assembly methods that consider context dependence between
neighbouring zinc fingers have been developed to yield functional
ZFNs (Bhakta et al., 2013; Gupta et al., 2012;Maeder et al., 2008;
Sander et al., 2011). The use of obligatory heterodimeric Fok1
domain developed by modification of wild-type Fok1 domain
significantly enhances specificity and reduces off-target effects
(Miller et al., 2007; Szczepek et al., 2007). Nonetheless, it remains
challenging to make efficient, specific ZFNs.
Zinc-finger nucleases have some disadvantages compared with
newly developed programmable nucleases. First, compared with
TALENs or RGENs, ZFNs have limited target availability. So far,
there is no open-source collection of 64 (4 9 4 9 4) zinc fingers
that covers all possible combinations of 3-bp subsites (Bae et al.,
2003; Segal et al., 1999). Furthermore, not all engineered ZFNs
create DSBs efficiently. Successful target sites are often in
guanine-rich regions, consisting of 50–GNN-30 (where N repre-
sents any nucleotide) repeat sequences. Thus, a single functional
ZFN pair can be obtained per ~100-bp DNA sequence on average
(Kim et al., 2009). This limitation is not too important for those
intending to knock out a gene, because a frameshift introduced
anywhere in the early coding sequence of the gene would suffice.
However, generating a functional ZFN may be challenging if one
particular target site is required, such as for creating a deletion,
insertion or substitution at a particular site. Second, ZFNs often
show low DNA-targeting activity (Ramirez et al., 2008) or are
cytotoxic owing to off-target effects (Cornu et al., 2008). Third, it
is difficult for nonspecialists to make ZFNs that target specific sites
routinely. Although an academic consortium developed an open-
source library of zinc-finger components and a screening protocol
to identify ZFNs with high affinity and efficiency (Maeder et al.,
2008, 2009), the library has not yet been widely accepted among
researchers. However, ZFNs also have advantages compared with
TALENs and RGENs. ZFN-encoding sequences (~1 kb 9 2) are
smaller than TALEN- (~3 kb 9 2) and RGEN-encoding sequences
(~4.2 kb for the protein + 0.1 kb RNA), facilitating delivery with
viral vectors that have limited cargo size, such as the adeno-
associated viral (AAV) vector. In addition, ZFPs are derived from
mammalian proteins, whereas TALENs and RGENs have a
bacterial origin. Thus, we speculate that ZFN immunogenicity is
lower than that of TALENs or RGENs, although a careful
comparison awaits further investigation.
Transcription activator-like effector nucleases
Like ZFNs, a TALEN consists of a designable, sequence-specific
DNA-binding domain and a nonspecific DNA cleavage domain
derived from FokI (Miller et al., 2011) (Figure 3). However,
TALENs use a different type of DNA-binding domain known as
transcription activator-like effectors (TALEs), which are derived
from a species of plant pathogenic bacteria. Whereas each zinc-
finger domain recognizes a 3-bp DNA sequence, there is a one-
to-one correspondence between TALE domains and base pairs.
TALEs are composed of tandem arrays of 33–35 amino acid
repeats, each of which recognizes a single base pair in the major
groove of DNA (Deng et al., 2012; Mak et al., 2012) (Figure 3b).
The specificity of each repeat is conferred by the two amino acids
at positions 12 and 13, known as repeat variable diresidues
(RVDs) (Figure 3c). To recognize guanine, adenine, cytosine and
thymine, RVD modules of Asn-Asn, Asn-Ile, His-Asp and Asn-Gly,
respectively, are widely used. TALENs can be designed to
target almost any given DNA sequence, which is a critical
advantage over other types of nucleases.
Compared with ZFNs, TALENs are much easier to design and
construct. TALENs are often built to bind 18- to 20-bp sequences.
In fact, larger TALENs may result in lower specificity (Guilinger
et al., 2014a). It is also tricky to construct longer TALE arrays
because of the recombination that can occur due to the highly
homologous TALE sequences (Holkers et al., 2013). Several
methods have been developed for the assembly of custom-
designed TALE arrays (Briggs et al., 2012; Cermak et al., 2011;
Reyon et al., 2012; Schmid-Burgk et al., 2013). The target site
binding affinity of an engineered TALE repeat array has been
reported to be as high as 96% (Hockemeyer et al., 2011; Miller
et al., 2011; Reyon et al., 2012). Additionally, genomewide
libraries of TALENs that target protein-coding genes (Kim et al.,
2013a) and microRNA-coding sequences (Kim et al., 2013b) have
been constructed.
As mentioned above, the relatively large size of TALEN-
encoding sequences can limit TALEN delivery and expression.
This limitation is especially restrictive in mammalian cells, where
viral vectors such as AAV are often used. Because of their low
immunogenic potential and the low oncogenic risk from host-
genome integration, AAV vectors are attractive as delivery
vehicles for programmable nucleases. However, the cargo size
of AAV is ~4.5 kb excluding the inverted terminal repeats,
preventing delivery of a TALEN pair using this method. Further-
more, the highly repetitive nature of TALEN sequences may
hinder their ability to be packaged and delivered by some viral
vectors (Holkers et al., 2013). Although it is not a major issue for
plant transformation, which is mostly performed using Agrobac-
terium T-DNA or plasmid DNA, the size of TALEN sequences
would pose challenges for DNA assembly in multiplexing or
multilocus targeting. The strategy of diversifying TALEN repeat
coding sequences may be helpful for overcoming this problem
(Yang et al., 2013).
CRISPR-Cas9 (RNA-guided engineered nucleases)
Zinc-finger nucleases and TALENs are relatively expensive due to
the difficulty of synthesis. Genome editing became more acces-
sible with the discovery and adaptation of the CRISPR-Cas9
system. This system, owing to its efficiency and ease of use, has
now become the most popular genome-editing tool.
CRISPR-Cas9 as an adaptive immune system in bacteria and
archaea. The RNA-guided DNA cleavage system naturally exists
as an adaptive form of immunity against invading phages or
plasmids in bacteria and archaea (Barrangou et al., 2007;
Makarova et al., 2006). These organisms ‘remember’ the
sequences of previously invading viral genomes and protect
themselves by recognizing and cutting those sequences when
they are encountered again. This type of acquired immunity
proceeds via the capture of foreign DNA fragments (~20 bp) from
invading phages or plasmids and the incorporation of these
sequences (termed protospacers) into the bacterial or archaeal
genome to form CRISPR. In type II CRISPR systems, these CRISPR
regions (memory elements) are transcribed as pre-CRISPR
RNA (pre-crRNA) and processed to form the target-specific
CRISPR RNA (crRNA). Trans-activating crRNA (tracrRNA), a target-
independent component, is also transcribed from the CRISPR
region and is involved in the processing of pre-crRNA (Deltcheva
et al., 2011). Both RNAs complexed with CRISPR-associated
protein 9 (Cas9) form an active DNA endonuclease system, and
destroy any DNA sequences that match the protospacer. In the
case of the system from Streptococcus pyogenes, which is the
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origin of the first engineered CRISPR-Cas9 system, the endonu-
clease can cleave a 23-bp target DNA sequence that is composed
of a 20-bp guide sequence identical to the crRNA (protospacer)
and a 50-NGG-30 (or, to a lesser extent, 50-NAG-30 (Hsu et al.,
2013; Jiang et al., 2013; Mali et al., 2013a) sequence known as
protospacer adjacent motif (PAM), which is recognized by Cas9
itself (Mojica et al., 2009). This PAM sequence can distinguish
between ‘self’ (protospacers) and ‘nonself’ (invader) DNA
sequences, priming the nonself sequences for a DSB at a site 3
bases before the PAM. Cas9 proteins derived from species other
than S. pyogenes recognize different PAM sequences (Cong
et al., 2013; Fonfara et al., 2014; Hou et al., 2013; Mojica et al.,
2009; Shah et al., 2013).
CRISPR-Cas9 for genome engineering. Here, we use the term
‘RNA-guided engineered nuclease (RGEN)’ to represent a new
type of genome-editing nuclease to avoid confusion with the
natural type II CRISPR-associated adaptive immune system in
bacteria.
In 2012, it was reported that guide RNA and purified Cas9
protein can cleave target DNA in vitro (Gasiunas et al., 2012;
Jinek et al., 2012). In January 2013, several groups independently
reported a new class of genome-editing nucleases (Cho et al.,
2013; Cong et al., 2013; Hwang et al., 2013; Jiang et al., 2013;
Jinek et al., 2013; Mali et al., 2013b), soon followed by their
application in plants (Li et al., 2013a; Shan et al., 2013). The
specificity of this system is determined by small guide RNAs rather
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Figure 3 Structure of transcription activator-like effector nucleases (TALENs). Each TALEN domain and module is shown in the same colour in both (a), (b)
and (c). (a) A schematic representation of a TALEN pair is shown. Each TALEN is composed of transcription activator-like effectors (TALEs) at the amino
terminus and the FokI nuclease domain at the carboxyl terminus. Target sequences of TALEN pairs are typically 30–40 bp in length, excluding a 12- to 21-
bp spacer. (b) A TALE protein in complex with target DNA. Each TALE repeat comprises 33–35 amino acids and recognizes a single base pair at the major
groove through the hypervariable residues at positions 12 and 13, which are called a repeat variable diresidue. This model was prepared from crystal
structures of TALE bound to DNA (Protein Database 3UGM) (Mak et al., 2012) and the FokI restriction endonuclease in the absence of DNA (Protein
Database 2FOK) (Wah et al., 1998) based on a previous analysis. (c) Recognition of bases by corresponding repeat variable diresidues.
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than by DNA-binding proteins such as ZFP or the TALE (Figure 4).
A single chimeric guide RNA (sgRNA), which is a fused form of
crRNA and tracrRNA (Jinek et al., 2012), simplifies RGEN
components further. Using the CRISPR-Cas system derived from
S. pyogenes [comprising the Cas9 protein along with guide RNA
(s)], in mammalian cells results in DSBs at target sites with a 20-bp
sequence matching the protospacer of the guide RNA and
an adjacent downstream NGG nucleotide sequence (PAM)
(Figure 4f). Site selection for RGENs is limited by the requirement
for the PAM sequence, which is recognized by Cas9. Thus, the
targetable sequences are 50-X20NGG-30 (or 50-X20NAG-30 to a
lesser extent), with X20 corresponding to the 20-bp crRNA
sequence and NGG or NAG corresponding to the PAM sequence,
which theoretically occurs on average once every 8 bp (including
NAG, once every 4 bp). When guide RNAs are transcribed by RNA
polymerase III under the control of the U6 promoter in cells, a
guanine at the 50 end is required (Cho et al., 2013, 2014). If the
first nucleotide in a guide RNA is not guanine, the addition of at
least one additional guanine base at the guide RNA 50 end is
required. Finally, unlike ZFNs and TALENs, RGENs can cleave
methylated DNA (Hsu et al., 2013).
Advantages of RGENs. A crucial advantage of RGENs over ZFNs
and TALENs is their simple and feasible preparation. The
complicated protein engineering required for constructing ZFN-
and TALEN-encoding sequences is not necessary for preparing
new RGENs. Because the Cas9 protein component remains
unchanged, new RGEN plasmids can be easily prepared by
cloning short guide DNA sequences into the guide RNA plasmid
backbone (Cong et al., 2013; Ding et al., 2013). This feasibility
facilitates the generation of large sets of vectors targeting various
genes, including genomewide libraries (Findlay et al., 2014;
Gilbert et al., 2014; Koike-Yusa et al., 2014; Konermann et al.,
2015; Shalem et al., 2014).
Multiplex genome editing is relatively easy using Cas9 nucle-
ases. In the case of ZFNs and TALENs, multiple pairs of nucleases
are needed for this process (Sollu et al., 2010). In contrast,
because Cas9 remains unchanged in all RGENs, one Cas9 and
multiple guide RNAs can disrupt multiple genes simultaneously.
This approach has been used for making multigene knockout
animals (Li et al., 2013a,b; Niu et al., 2014; Wang et al., 2013)
and plants (Xie et al., 2015).
Furthermore, new RGENs can be made without plasmids. The
Cas9 protein and in vitro transcribed guide RNA can be easily
prepared. The plasmid-free approach also has the advantage of
being safer for therapeutic applications (Kim et al., 2014;
Ramakrishna et al., 2014; Zuris et al., 2015).
Disadvantages of RGENs. The coding sequence of S. pyogenes
Cas9 is ~4.2 kb. Even though the other designed nucleases act as
dimers, this Cas9 sequence is longer than that encoding a TALEN
monomer (~3 kb) or a ZFN monomer (~1 kb). Therefore, delivery
of RGENs via viral systems is somewhat challenging. For proper
transcription, a promoter and a polyadenylation sequence are
required in addition to the Cas9 sequence. The sgRNA is
approximately 100 bp, which must be delivered in parallel with
the Cas9 sequence to produce an active RGEN. Inclusion of an
RNA III polymerase promoter such as the U6 promoter for sgRNA
transcription means that ~500 bp is needed for sgRNA. RGENs
have been delivered to various types of plants using polyethylene
glycol (PEG)–protoplast transfection, Agrobacterium-mediated
transformation and microparticle bombardment, all of which
have relatively large cargo capacities that are sufficient for RGEN
accommodation (Bortesi and Fischer, 2015). The efficiency of
RGEN-mediated genome editing clearly is affected by the delivery
method in plant as well as animal cells. For example, PEG-
mediated protoplast transfection resulted in a 10-fold higher
mutation rate than that by Agrobacterium-mediated transforma-
tion in N. benthamiana (Li et al., 2013a,b). Although it is less of
an issue for plant biotechnology, efficient application of RGENs in
mammalian cells sometimes requires the use of a specific DNA
delivery system such as lentivirus that can accommodate the
S. pyogenes RGEN system; AAV, with its cargo size limited to less
than 4.8 kb, cannot easily do so. Efforts have been made to
reduce the size of RGEN-encoding sequences (using a short
promoter and polyadenylation sequence) for use in AAV (Swiech
et al., 2015). In addition, CRISPR-Cas systems from other species,
some of which involve smaller Cas9 proteins, should be helpful in
this regard. Recently, RGEN AAV, which contains the sequence
encoding the smaller Staphylococcus aureus Cas9 (more than
1 kb shorter than that encoding S. pyogenes Cas9) and guide
RNA in one shuttle vector, has been reported (Ran et al., 2015).
These developments allow for the delivery of RGENs via AAV,
which may be important for therapeutic applications that often
require high delivery efficiency.
Modification of designed nucleases
Designed nickases
Nonhomologous end-joining-mediated repair of DSBs induced by
designed nucleases inevitably causes the formation of uncon-
trolled and undesirable indels at the target site and, potentially, at
off-target sites, even in the presence of a homologous donor
template for HDR. In higher vertebrates and plants, DSBs are
Figure 4 Structure of RNA-guided engineered nucleases (RGENs). Each domain of Cas9 is shown using the same colours in (a) to (h). (a) Domain
organization of S. pyogenes Cas9. HNH and RuvC domains are nuclease domains of Cas9. Topo and CTD are protospacer adjacent motif (PAM)-interacting
domains. Arg, Arg-rich bridge helix; REC, recognition lobe; Topo, topoisomerase-homology domain; CTD, C-terminal domain. (b, c) Schematic
representations (b) and three-dimensional models (c) of Cas9, target DNA and single guide RNA. Guide RNA loading induces conformational
rearrangements in Cas9, leading to the formation of a central channel that may accommodate target DNA. Regions marked with orange, blue and pink
boxes represent the HNH catalytic site, the RuvC catalytic site and the PAM recognition site, respectively, and are depicted in greater detail in (d), (e) and (f),
respectively. This model was prepared from Protein Database 4UN3, 4CMP based on previous analyses (Anders et al., 2014; Jinek et al., 2014). (d) A three-
dimensional model of the HNH domain, which cleaves the complementary DNA strand. Here, the nuclease activity of the HNH domain is inactivated by the
introduction of a H840A mutation, leading to preservation of the target strand. (e) A three-dimensional model of the RuvC domain, which cleaves the
noncomplementary DNA strand. Here, the target DNA strand is cleaved. (f) A three-dimensional model and schematic representation of PAM recognition
by Cas9. Cas9–RNA recognizes the PAM GG dinucleotide using Arg 1333 and Arg 1335, and positions the target DNA duplex such that the +1 phosphate
(orange circle) interacts with the topo-homology domain. This interaction leads to local strand separation immediately upstream of the PAM, which
promotes heteroduplex formation between the guide RNA and the complementary target DNA strand. This model was prepared from Protein Database
4UN3, 4CMP based on previous analyses (Anders et al., 2014; Jinek et al., 2014).
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primarily repaired by NHEJ. Altered (or ‘resistant’) sequences with
indels at the cleavage site cannot be retargeted with the original
designed nuclease. To correct these resistant sequences, they
must first be identified; then, programmable nucleases that target
each resistant sequence must be newly designed. Given that
NHEJ-mediated indel formation is hard to predict, a variety of
resistant sequences can be generated, making it difficult to
design nucleases that target all of the resistant sequences. DSBs
generated in the resistant sequences can then lead to the creation
of a second set of resistant sequences, again through NHEJ-
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mediated repair of the DSBs, preventing precise genome editing.
To avoid the generation of unwanted mutations by designed
nucleases, nickases that produce single-strand breaks (SSBs)
rather than DSBs have been proposed as an alternative. Chem-
ically, SSBs are discontinuities in the covalently linked carbon-
phosphate backbone of one strand in the DNA double helix. A
SSB can result in a discontinuity of the genetic information in
the affected strand. However, SSBs perturb genetic information
much less frequently than do DSBs because the other, intact
strand can be used as a template to guide the correction of the
damaged strand. Naturally, one of the most common sources of
SSBs is oxidative attack by endogenous reactive oxygen species.
A SSB can enhance HDR, although the efficiency is lower than
that of the nucleases (Davis and Maizels, 2011; McConnell
Smith et al., 2009). SSBs are repaired via the high-fidelity base
excision repair (BER) pathway (Dianov and H€ubscher, 2013) and
do not activate the NHEJ pathway, preventing generation of
unwanted indels. Thus, nickases can lead to precise genome
editing.
The first designed nickases were modified ZFNs that
consisted of one intact and one mutant FokI subunit with a
mutation at the active catalytic site (Kim et al., 2012; Ramirez
et al., 2012; Wang et al., 2012). ZF nickase heterodimers
generate a SSB at the target site and do not cause undesirable
DSBs at either the target site or off-target sites (Kim et al.,
2012; Wang et al., 2012). ZF nickases induced precise genome
editing via HDR with a lower efficiency than the corresponding
ZF nucleases (Kim et al., 2012; Ramirez et al., 2012; Wang
et al., 2012). Other designed nickases derived from TALENs
have also been reported and tested in vitro (Gabsalilow et al.,
2013).
Cas9 has two active catalytic domains, RuvC and HNH, which
each cleave one strand and together generate a blunt-ended DSB
(Figures 4d,e and 5a). Two types of Cas9 nickases have been
constructed via the introduction of point mutations in RuvC
(D10A) and HNH (H840A) (Figure 5b); both nickases have been
shown to form SSBs (Gasiunas et al., 2012; Jinek et al., 2012;
Sapranauskas et al., 2011). RNA-guided engineered nickases
(RGENickases) that contain the S. pyogenes Cas9 HNH+/RuvC-
nickase mutant (D10A), which has better efficiency than the
HNH-/RuvC+(H840A) mutant, lead to high-fidelity HDR with
negligible NHEJ-driven mutations (Cong et al., 2013; Fauser
et al., 2014; Mali et al., 2013b).
To improve DSB specificity, paired nickases, like dimeric ZFNs
and TALENs, can be used to increase the number of bases that are
recognized. Because individual nicks in the genome are repaired
with high fidelity through the BER pathway, off-target SSBs
would be precisely repaired. Furthermore, because the probability
that two nickases would make off-target SSBs that are close to
each other in the genome is extremely low, the off-target
mutation rate would be dramatically reduced. Paired nickases
designed to make two SSBs, one on each of the two DNA strands,
collectively generate a composite DSB, which will lead to indel
formation through NHEJ. Properly spaced ‘paired nickases’
showed efficiency comparable to that of the corresponding
nuclease with up to 500-fold reduced off-target activity in human
and mouse cells (Cho et al., 2014; Kim et al., 2012; Mali et al.,
2013a; Ran et al., 2013a). Comparable with the results from
experiments using animal cells, a recent study on Arabidopsis
found that the on-target mutagenic rate of paired nickases was
the same as that of the Cas9 nuclease (Schiml et al., 2014).
RNA-guided FokI nucleases
An RNA-guided FokI nuclease, analogous to dimeric ZFNs or
TALENs, is a fusion of a dimerization-dependent FokI nuclease
domain as the cleavage domain and a catalytically inactive Cas9
(termed dead Cas9; dCas9) as the DNA-binding domain
(Guilinger et al., 2014b; Tsai et al., 2014) (Figure 5c). As with
paired nickases, highly specific gene targeting is feasible using
RNA-guided FokI nucleases (RFNs) because of the increased
number of bases that are recognized at a given site.
Transcriptional regulation using dead Cas9
Cas9 coupled with guide RNA has two key properties. One is the
ability to bind to DNA at a targeted site, and the other is its
catalytic function. A catalytically inactivated Cas9 (dCas9) has
been repurposed to allow controlled transcriptional regulation of
genes. Whereas transcriptional regulation using dCas9 has only
transient effects, similar to RNAi, active Cas9 elicits permanent
changes in the genome.
Although RNAi is a popular tool for knockdown of target gene
expression, RNAi-based experiments are often complicated by
inefficiency or unpredictable off-target effects. Transcriptional
regulation using dCas9 represents a good alternative, which can
elicit both up- and down-regulation of the expression of multiple
genes simultaneously (Bikard et al., 2013; Gilbert et al., 2013; Qi
et al., 2013a,b). Binding of a dCas9–guide RNA ribonuclear
protein complex to an appropriate DNA element can repress
transcription by blocking transcriptional elongation, RNA poly-
merase binding or transcription factor binding (Qi et al., 2013a,
b). CRISPR-based interference using dCas9–guide RNA complexes
themselves is less efficient in eukaryotes compared to prokaryotes
5’
3’ 5’
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Figure 5 Modifications of Cas9 as a genome engineering platform. (a)
Cas9 nuclease. The Cas9 nuclease cleaves both strands of DNA via its
RuvC and HNH nuclease domains, each of which makes a nick in a DNA
strand, leading to the generation of blunt-end DSBs. (b) Cas9 nickases.
Either catalytic domain can be inactivated to generate nickase mutants
that each make single-strand DNA breaks. (c) RNA-guided FokI nuclease.
Here, both of the Cas9 catalytic domains are inactivated to generate dead
Cas9 (dCas9). Two FokI–dCas9 fusion proteins are recruited to adjacent
target sites by two different guide RNAs to facilitate FokI dimerization,
leading to a double-strand DNA cleavage between the two target sites by
the activated FokI dimer.
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(Gilbert et al., 2013). The fusion of a transcriptional activator or
repressor such as VP64 or KRAB, respectively, leads to more
efficient transcriptional activation or suppression in human cells
(Gilbert et al., 2013; Konermann et al., 2013). The efficiency of
transcriptional regulation by dCas9 has also been improved by
modifying the structure of the guide RNA to recruit additional
activators or cofactors (Konermann et al., 2015; Zalatan et al.,
2015).
Comparison of the three types of engineered
nucleases
Efficacy
Not all newly designed nucleases are functional and equally
efficient (Table 1), and it is difficult to predict the efficiency of
newly designed nucleases. ZFNs usually exhibit relatively low
efficiency for generating DSBs in cultured cells or organisms
compared to TALENs or RGENs. Gene knockout efficiency with
functional TALENs is difficult to predict and has been reported to
range from 1% to ~60% in mammalian cells (Kim et al., 2013a;
Reyon et al., 2012). RGENs also have shown a wide range of
genome-editing activities (2.3–79%) in cultured cells (Cho et al.,
2013; Cong et al., 2013; Ding et al., 2013; Jinek et al., 2013;
Mali et al., 2013b). Both the target cell type and the delivery
method seem to significantly affect the activity of all three classes
of nucleases. Recently, a program was designed to enable
approximate prediction of the activity of designed guide RNAs
based on high-throughput efficiency data from 1841 guide RNAs
(Doench et al., 2014). Although the standard, most accurate
method for determining the activity of individual guide RNAs is
cell-based analysis, this in silico analysis can be useful for selecting
several highly active guide RNA candidates that could then be
subjected to actual evaluation in cells, which requires much more
labour, time and cost than in silico analysis. This in silico program-
assisted approach can be useful for obtaining highly active guide
RNAs for gene knockout, for which a large number of guide RNA
can be designed. However, the users of this program should be
aware of the possibility that sgRNA activity predicted by this
program can be different from the actual sgRNA activity
measured by cell-based analysis. Similar programs for plant
genome editing are also available (Xie et al., 2014).
Safety
The specificity of ZFNs and TALENs can be determined by the
number of zinc fingers and TALE modules the nucleases contain.
More modules are generally thought to signify a higher
specificity. However, too many modules can elevate the possibility
of partial binding at many unwanted sites. Theoretically, nucle-
ases should recognize DNA sequences of at least 16 bp to
eliminate potential off-target effects in the human genome
because the complexity of 16-bp sequences (416 = 4.3 9 109) is
greater than the size of the human haploid genome (3.2 9 109).
However, modifying crop plant genomes that are larger than the
human genome may require a longer target site sequence to
minimize off-target effects. In reality, however, all three nucleases
with target site sizes greater than 16 bp have shown some off-
target effects (Fu et al., 2013; Gabriel et al., 2011; Hsu et al.,
2013; Mussolino et al., 2011; Pattanayak et al., 2011). In the
case of ZFNs, too many off-target cleavages are thought to cause
cytotoxicity (Cornu et al., 2008).
Compared to dimeric ZFNs and TALENs, RGENs theoretically
have lower specificity because of functioning as monomers.
Several studies have examined off-target effects of RGENs (Cho
et al., 2014; Cradick et al., 2013; Fu et al., 2013; Hsu et al.,
2013; Mali et al., 2013a; Pattanayak et al., 2013). One study
showed that RGENs can induce off-target mutations at sites that
differ by up to five nucleotides from on-target sites, which implies
that thousands of potential off-target cleavages can occur in the
human genome for every RGEN (Fu et al., 2013), whereas some
studies reported that off-target mutations were below the
detection range when analysed by unbiased whole-genome
(Veres et al., 2014) or exome sequencing (Cho et al., 2014).
Recent genomewide off-target analysis based on deep sequenc-
ing also revealed a broad spectrum of RGEN specificities (Frock
et al., 2015; Kim et al., 2015; Tsai et al., 2015; Wang et al.,
2015).
Several strategies have been suggested and found to minimize
or prevent off-target effects (Koo et al., 2015). First, when
designing a nuclease, choosing unique target sites that lack highly
homologous sequences elsewhere in the genome is recom-
mended. Many web-based programs have been developed for
searching for potential TALEN or RGEN off-target sites (Bae et al.,
2014; Heigwer et al., 2013, 2014; Hsu et al., 2013). Second,
RGEN off-target effects can be modulated by controlling the level
or duration of nuclease expression (Hsu et al., 2013). Third, the
use of recombinant proteins and in vitro transcribed RNA, rather
than plasmids encoding these components, can further reduce
the frequency of off-target mutations due to the rapid degrada-
tion of the protein and RNA in cells (Gaj et al., 2012; Kim et al.,
2014; Ramakrishna et al., 2014). Jin-Soo Kim’s group and we
have recently reported that plasmid-free delivery of Cas9 protein
and guide RNA can dramatically reduce off-target mutations
without reducing efficiency (Kim et al., 2014; Ramakrishna et al.,
2014). Additionally, sgRNAs truncated at the 50 end (length less
Table 1 Comparison of three classes of designed nucleases
ZFN TALEN RGEN (CRISPR/Cas9)
Recognition
site
18–36 bp
per ZFN
pair
30–40 bp
per TALEN
pair
22 bp (20-bp guide
sequence + 2-bp
protospacer adjacent
motif (PAM) from
Streptococcus
pyogenes)
Restriction in
target site
G-rich Start with T End with an NGG
(NAG: lower activity)
sequence
Success rate Low High High
Off-target effects High Low Variable
Cytotoxicity Variable to high Low Low
Size ~1 kb 9 2 ~3 kb 9 2 4.2 kb (Cas9 from
Streptococcus
pyogenes) + 0.1 kb
(sgRNA)
Ease of
engineering
Difficult Moderate Easy
Ease of
multiplexing
Low Low High
ZFN, zinc-finger nuclease; TALEN, transcription activator-like effector nuclease;
RGEN, RNA-guided engineered nuclease; CRISPR, clustered regularly inter-
spaced short palindromic repeat; Cas9, CRISPR-associated protein 9; sg RNA,
single-chain guide RNA.
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than 20 bp) (Fu et al., 2014) or those with two extra guanine
nucleotides at the 50 end (Cho et al., 2014; Kim et al., 2015)
are reported to reduce off-target mutations up to 5000-fold
(truncated sgRNA) or 660-fold (sgRNA with two extra guanine
nucleotides) without alteration of mutation efficiencies at target
sites. Paired nickases (Ran et al., 2013a) or RNA-guided FokI
nucleases (Guilinger et al., 2014b; Tsai et al., 2014) for
knockout of genes can be good alternatives to nucleases with
minimum off-target effects (Ran et al., 2013a; Tsai et al.,
2014).
Conclusion
Generation of DSBs in a targeted manner using designed
nucleases greatly facilitates genome editing. Recent break-
throughs in programmable nucleases have made genome editing
an efficient and affordable process. Furthermore, technologies for
‘reading’ and ‘writing’ (that is, sequencing and synthesizing,
respectively) genomes are currently being developed in parallel
with genome editing.
Nonetheless, several aspects of programmable nuclease
technology, including activity, off-target effects, ease of engi-
neering and delivery, can be improved. Recently published
analyses based on deep sequencing showed Cas9 nuclease-
induced hard-to-predict off-target cleavages across the whole
genome (Frock et al., 2015; Kim et al., 2015; Tsai et al., 2015;
Wang et al., 2015), raising a safety issue. To increase the
efficiency of precise genome editing, DSB repair pathways can
be controlled either genetically or pharmacologically. Recently,
several methods that improve HDR efficiency by reducing NHEJ
have been developed (Chu et al., 2015; Maruyama et al.,
2015; Yu et al., 2015). If more precise genome editing can be
performed, breeders will be able to manipulate the genomes of
plants and animals with reduced adverse effects. In addition,
genome-scale libraries of designed nucleases or transcriptional
regulators (Findlay et al., 2014; Gilbert et al., 2014; Koike-Yusa
et al., 2014; Konermann et al., 2015; Shalem et al., 2014) can
be used for deciphering new biological findings by enabling
high-throughput loss- and gain-of-function studies. In the
future, designed nucleases with improved efficiency and
precision are expected to open a new era of biological
research, medicine and biotechnology.
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